A Network Approach to Standardization of BMT Pathways
Peter A. McSweeney, Carlos R. Bachier, Jesús G. Berdeja, Hana Safah, Mohammed M. Elayan, Charles F. LeMaistre, Rocky Lee Billups, Tonya Cox · Transplantation and Cellular Therapy · 2015
The Sarah Cannon Blood Cancer Network (SCBCN) consists of 6 programs in the US performing over 850 HSCTs annually. In the fall of 2012, the SCBCN physician leaders proposed development of standardized disease-based BMT pathways. These included background information on the diseases, indications for transplant and treatment methods to be used. Anticipated benefits included improved quality and efficiency of transplantation throughout network, improved data collection, and a better platform for collaborative research amongst the programs.